We’ve all lived through the disruptive COVID-19 pandemic and witnessed how it has shaped our lives. But what if another pandemic has been unfolding right under our noses, without the lockdowns, daily headlines or widespread panic? 

Antimicrobial resistance (AMR), often referred to as the 'silent pandemic', is threatening one of modern medicine's greatest achievements: our ability to treat infections. And for a generation that has grown up taking effective antibiotics for granted, perhaps we must question what will happen when they stop working.  

"Treatments we once relied upon are becoming less effective, leaving us vulnerable to infections that modern medicine had seemingly brought under control."

The Science Behind It

Antimicrobial resistance (AMR) occurs when microorganisms, including bacteria, fungi, viruses and parasites, evolve mechanisms that allow them to survive antimicrobial treatments. In bacteria, resistance can arise through spontaneous genetic mutations or horizontal gene transfer (HGT), where genetic material is exchanged between bacteria rather than inherited from parent cells. One mechanism, known as conjugation, allows bacteria to transfer plasmids, small DNA molecules that can carry antibiotic resistance genes, directly between cells. 

And here's the worrying part: we may be accelerating this process ourselves. 

The misuse of antibiotics in healthcare and agriculture creates selective pressure. This favours bacteria with resistance mechanisms. While susceptible  bacteria are eliminated, resistant strains survive, reproduce and spread their resistance genes. Through natural selection, these populations become increasingly difficult to treat. 

The result? Treatments we once relied upon are becoming less effective, leaving us vulnerable to infections that modern medicine had seemingly brought under control.

Why Should Our Generation Care?

"AMR is a crisis developing across generations. By 2050, annual deaths directly attributable to bacterial resistance could reach 1.91 million worldwide."

For many of us, antibiotics have always been there. But what happens when infections we consider easily treatable begin resisting our most reliable medicines? 

Take urinary tract infections (UTIs), commonly caused by Escherichia coli. Certain strains produce extended-spectrum β-lactamases (ESBLs), enzymes capable of breaking down commonly used β-lactam antibiotics, including many penicillins and cephalosporins. This can significantly restrict treatment options for an infection particularly common among young women. 

Or consider gonorrhoea, a sexually transmitted infection caused by Neisseria gonorrhoeae. Resistance to multiple antibiotics has emerged, including ceftriaxone, a key first-line treatment. In England, 14 ceftriaxone-resistant cases were reported during the first five months of 2025, exceeding the 13 recorded throughout 2024.  Although such resistance remains uncommon, its emergence is particularly relevant to young, sexually active populations. 

Even Staphylococcus aureus, a bacterium commonly found on our skin, can cause serious infections. Methicillin-resistant S. aureus (MRSA) carries resistance mechanisms involving altered penicillin-binding proteins, reducing the effectiveness of many β-lactam antibiotics. This poses challenges for wound infections, surgery and hospital care. 

And the implications extend beyond treating infections themselves. Chemotherapy,  organ transplantation and routine surgery all depend on effective antibiotics to manage bacterial complications. 

Much like climate change, AMR is a crisis developing across generations. By 2050, annual deaths directly attributable to bacterial resistance could reach 1.91 million worldwide.

Our generation may have inherited the benefits of the antibiotic era, but are we at risk of witnessing its decline?

Is It Too Late To Fight Back? 

"From laboratories to lecture halls, we have opportunities to turn awareness into action."

Thankfully, the future of antimicrobial resistance isn't set in stone. In fact, organisations worldwide are already developing innovative ways to fight back. 

Take Médecins Sans Frontières (MSF), for example. Working in conflict-affected and resource-limited regions, MSF has developed the Mini-Lab, a portable bacteriology laboratory designed to identify bacterial pathogens and perform antibiotic susceptibility testing. By identifying which antibiotics remain effective against an infection, healthcare professionals can make more targeted treatment decisions, reducing unnecessary antibiotic use. 

Meanwhile, the World Health Organization (WHO) coordinates World AMR Awareness Week every November, encouraging communities, healthcare professionals and  policymakers to take action. Its One Health approach recognises that human, animal and environmental health are interconnected, making collaboration essential to  controlling resistance. 

So, where does our generation fit into all of this? 

For aspiring scientists, opportunities lie in developing novel antibiotics, investigating bacteriophage therapy and using genomic sequencing to track resistance genes. Future healthcare professionals can promote responsible prescribing. Students can  participate in research, and initiatives such as World AMR Awareness Week. 

And even without a career in science, our actions matter. Understanding when  antibiotics are necessary, following medical advice and challenging misinformation will help to protect their effectiveness. 

Our generation doesn't have to wait until resistance becomes an even greater crisis to get involved. From laboratories to lecture halls, we have opportunities to turn awareness into action.

What Can The Future Look Like?

Antimicrobial resistance is not a hypothetical pandemic waiting to emerge. It is already here, quietly challenging the foundations of modern medicine. 

Yet, unlike many global health threats, its future is not inevitable. The choices made by scientists, healthcare professionals, governments and individuals today will influence  how severely resistance affects the generations to come. 

We have grown up in a world where antibiotics are often taken for granted. Whether future generations can enjoy that same protection may depend on what we do now. 

Perhaps the real question isn't whether the silent pandemic will become our generation's loudest problem, but whether we will listen before it does.